
Veru VERU
€ 2.59
-7.98%
Quartalsbericht 2026-Q2
hinzugefügt 13.05.2026
Veru ROE 2011-2026 | VERU
ROE Jährlich Veru
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -123.97 | -116.97 | -473.38 | -46.75 | 4.86 | -63.01 | -37.17 | -81.2 | -13.65 | 1.02 | 13.12 | 8.67 | 45.67 | 63.17 | 32.23 | 41.76 | 50.45 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 63.17 | -473.38 | -40.89 |
ROE Vierteljährlich Veru
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -84.4 | -114.06 | -133.29 | -118.92 | -148.08 | -122.47 | -100.97 | -67.37 | -128.02 | -253.78 | -310.29 | -294.26 | -347.14 | -305.48 | -161.0 | -86.62 | -26.05 | -8.8 | -0.2 | 39.45 | 67.11 | 104.19 | 141.36 | 94.87 | 48.38 | 1.89 | -44.6 | -39.28 | -33.95 | -28.63 | -23.3 | -26.99 | -26.7 | -22.5 | -26.19 | -20.55 | -20.18 | -16.87 | -11.38 | -3.21 | 4.07 | 5.92 | 14.45 | 12.9 | 8.77 | 9.36 | 7.73 | 9.99 | 32.99 | 31.17 | 32.97 | 42.4 | 50.79 | 59.0 | 68.93 | 70.18 | 46.09 | 38.04 | 39.33 | 5.28 | 2.49 | 15.88 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 141.36 | -347.14 | -33.06 |
ROE anderer Aktien in der Arzneimittelhersteller
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
-76.05 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-5.67 | $ 5.6 | -1.23 % | $ 83.2 M | ||
|
HEXO Corp.
HEXO
|
-342.25 | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-53.8 | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
-91.16 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
-0.27 | $ 2.68 | -2.55 % | $ 1.03 B | ||
|
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
-9.8 | $ 37.64 | -0.03 % | $ 1.38 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | ||
|
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.0 | -0.99 % | $ 108 M | ||
|
Organogenesis Holdings
ORGO
|
12.33 | $ 2.34 | -1.68 % | $ 297 M | ||
|
Pacira BioSciences
PCRX
|
-12.79 | $ 22.99 | -1.58 % | $ 1.06 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 1.09 | -0.91 % | $ 1.35 M | ||
|
Aurora Cannabis
ACB
|
0.26 | $ 3.04 | -1.3 % | $ 167 M | ||
|
Solid Biosciences
SLDB
|
-96.84 | $ 7.14 | -1.11 % | $ 625 M | ||
|
Jupiter Wellness
JUPW
|
-194.84 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
-14.85 | $ 1.06 | -1.85 % | $ 101 M | ||
|
Tilray
TLRY
|
-43.81 | $ 4.98 | -2.73 % | $ 3.08 B | ||
|
cbdMD
YCBD
|
-28.24 | $ 0.69 | -1.72 % | $ 2.78 M | ||
|
Evolus
EOLS
|
223.5 | $ 6.73 | 3.38 % | $ 434 M | ||
|
Sundial Growers
SNDL
|
-88.87 | $ 1.42 | -2.74 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
10.07 | $ 8.32 | -0.83 % | $ 445 M | ||
|
Neoleukin Therapeutics
NLTX
|
-34.11 | - | - | $ 193 M | ||
|
Assertio Holdings
ASRT
|
-32.33 | $ 23.48 | 0.04 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
-420.27 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
-28.34 | $ 5.06 | -1.94 % | $ 1.88 B | ||
|
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
-66.33 | $ 6.65 | 1.99 % | $ 263 M | ||
|
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
53.37 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
-17.44 | $ 4.23 | -0.35 % | $ 211 M | ||
|
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
-23.89 | $ 16.48 | 1.04 % | $ 19.2 B | ||
|
Zomedica Corp.
ZOM
|
-70.94 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
-14.37 | $ 0.62 | 0.35 % | $ 22.3 M | ||
|
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
-14.02 | $ 0.71 | -6.82 % | $ 3.05 M | ||
|
TherapeuticsMD
TXMD
|
-2.12 | $ 2.2 | 20.88 % | $ 25.5 M |